The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net operating revenues | 2,965 | 3,106 | 3,087 | - |
| Salaries and benefits | 1,322 | 1,356 | 1,357 | - |
| Supplies | 441 | 446 | 460 | - |
| Contract labor | - | - | 39 | - |
| Medical specialist fees | 163 | 169 | 165 | - |
| Other segment items | 734 | 859 | 696 | - |
| Depreciation and amortization | 114 | 109 | 106 | - |
| Interest expense | 214 | 221 | 218 | - |
| Interest income | 1 | 0 | 1 | - |
| Impairment and (gain) loss on sale of businesses, net | -90 | -164 | 21 | - |
| Loss from early extinguishment of debt | -8 | -8 | -33 | - |
| Equity in earnings of unconsolidated affiliates | 4 | 0 | 5 | - |
| Provision for income taxes | 89 | 61 | -173 | - |
| Net (loss) income | -25 | 160 | 171 | 345 |
| Depreciation and amortization | 114 | 109 | 106 | 211 |
| Deferred income taxes | 0 | 18 | -270 | 9 |
| Stock-based compensation expense | 3 | 4 | 0 | 7 |
| Impairment and (gain) loss on sale of businesses, net | -90 | -164 | 21 | -263 |
| Loss from early extinguishment of debt | -8 | -8 | -33 | 138 |
| Other non-cash expenses, net | -40 | -39 | -42 | -92 |
| Patient accounts receivable | 141 | -24 | -101 | 26 |
| Supplies, prepaid expenses and other current assets | 97 | -39 | -18 | 13 |
| Accounts payable, accrued liabilities and income taxes | -128 | 50 | -132 | 46 |
| Other | -19 | 21 | 21 | 62 |
| Purchases of investments in unconsolidated affiliates | - | 0 | 0 | 0 |
| Net cash (used in) provided by operating activities | -297 | 266 | 69 | 208 |
| Acquisitions of facilities and other related businesses | 5 | 0 | 1 | 0 |
| Purchases of property and equipment | 76 | 94 | 65 | 176 |
| Proceeds from disposition of hospitals and other ancillary operations | 1,108 | 242 | -1 | 1,013 |
| Proceeds from sale of property and equipment | - | 0 | 3 | 5 |
| Purchases of available-for-sale debt securities and equity securities | 42 | 32 | 35 | 72 |
| Proceeds from sales of available-for-sale debt securities and equity securities | 45 | 36 | 29 | 58 |
| Increase in other investments | 7 | 10 | 11 | 42 |
| Net cash provided by investing activities | 1,023 | 142 | -81 | 786 |
| Repurchase of restricted stock shares for payroll tax withholding requirements | 2 | 0 | 0 | 2 |
| Deferred financing costs and other debt-related costs | 7 | 7 | 7 | 2 |
| Proceeds from noncontrolling investors in joint ventures | - | 0 | 1 | 1 |
| Redemption of noncontrolling investments in joint ventures | - | 1 | 2 | - |
| Issuance of long-term debt | - | 0 | 1,770 | 700 |
| Distributions to noncontrolling investors in joint ventures | 57 | 44 | 24 | 96 |
| Other borrowings | 20 | 25 | 1 | 15 |
| Proceeds from abl facility | 123 | 0 | 832 | 2,189 |
| Repayments of long-term indebtedness | 351 | 244 | 2,892 | 3,380 |
| Net cash used in financing activities | -274 | -271 | -321 | -575 |
| Net change in cash and cash equivalents | 452 | 137 | -333 | 419 |
| Cash and cash equivalents at beginning of period | 260 | 123 | 37 | - |
| Cash and cash equivalents at end of period | 712 | 260 | 123 | - |
COMMUNITY HEALTH SYSTEMS INC (CYH)
COMMUNITY HEALTH SYSTEMS INC (CYH)